Individuals with autism spectrum disorder are heterogeneous in clinical presentation, concurrent disorders, and developmental outcomes. This study characterized the clinical co-occurrences and potential subgroups in 160 children with autism spectrum disorders who presented to The Autism Center between 1999 and 2003. Medical and psychiatric co-occurrences included sleep disorders, epilepsy, food intolerance, gastrointestinal dysfunction, mood disorder, and aggressive and self-injurious behaviors. Sleep disorders were associated with gastrointestinal dysfunction (P < .05) and mood disorders (P < .01). Food intolerance was associated with gastrointestinal dysfunction (P = .001). Subjects with mood disorder tended to develop aggressive or self-injurious behaviors (P < .05). Developmental regression was not associated with increased co-occurrence of medical or psychiatric disorders. Medical co-occurrence did not present as a risk factor for psychiatric co-occurrence, and vice versa. These results showed a high prevalence of multiple medical and psychiatric co-occurrences. There may be common pathophysiologic mechanisms resulting in clinical subgroups of autism spectrum disorders. Recognition of the co-occurrence of concurrent disorders may provide insight into the therapeutic strategy.
Mouridsen SE, Rich B., Isager T.The natural history of somatic morbidity in disintegrative psychosis and infantile autism: a validation study. Brain Dev.1999 ;21:447-452.
2.
Gillberg C.Early symptoms in autism. In: Gillberg C, ed. Diagnosis and Treatment of Autism. New York, NY: Plenum Press;1989:23-32.
3.
Rapin I., Katzman R.Neurobiology of autism. Ann Neurol.1998; 43:7-14.
4.
Tager-Flusberg H., Joseph RMIdentifying neurocognitive phenotypes in autism . Philos Trans R Soc Lond B Biol Sci.2003 ; 358:303-314.
5.
Beglinger LJ , Smith THAreview of subtyping in autism and proposed dimensional classification model. J Autism Dev Disord. 2001;31:411-422.
6.
Hrdlicka M., Dudova I., Beranova I., et al. Subtypes of autism by cluster analysis based on structural MRI data. Eur Child Adolesc Psychiatry. 2005;14:138-144.
7.
Stevens MC, Fein DA, Dunn M., et al. Subgroups of children with autism by cluster analysis: a longitudinal examination. J Am Acad Child Adolesc Psychiatry. 2000;39:346-352.
8.
Miles JH, Takahashi TN, Bagby S., et al. Essential versus complex autism: definition of fundamental prognostic subtypes. Am J Med Genet.2005;135:171-180.
9.
Spence SJ, Sharifi P., Wiznitzer M.Autism spectrum disorder: screening, diagnosis, and medical evaluation. SemPediatr Neurol.2004;11:186-195.
10.
White JFIntestinal pathology in autism. Exp Biol Med.2003;228:639-649.
11.
Jyonouchi H. , Geng L., Ruby A., Zimmerman-Bier B.Dysregulated innate immune responses in young children with autism spectrum disorders: their relationship to gastrointestinal symptoms and dietary intervention. Neuropsychobiol . 2005;51:77-85.
12.
Gupta S.Immunological treatments for autism. J Autism Dev Disord. 2000;30:475-479.
13.
Tuchman R., Rapin I.Epilepsy in autism. Lancet Neurol.2002;1:352-358.
14.
Richdale Al , Prior MRThe sleep/wake rhythm in children with autism . Eur Child Adolesc Psychiatry. 1995;4:1-11.
15.
Thirumalai SS, Shubin RA, Robinson R.Rapid eye movement sleep behavior disorder in children with autism. J Child Neurol.2002 ;17:173-178.
16.
Ghaziuddin M., Ghaziuddin N., Greden J.Depression in persons with autism: implications for research and clinical care. J Autism Dev Disord. 2002;32:299-306.
17.
Lainhart JE , Folstein SEAffective disorders in people with autism: a review of published cases. J Autism Dev Disord. 1994; 24:587-601.
18.
Gillberg C.Asperger's syndrome and recurrent psychosis-a case study. J Autism Dev Disord. 1985;15:389-397.
19.
Stahlberg O. , Soderstrom H., Rastam M., Gillberg C.Bipolar disorder, schizophrenia, and other psychotic disorders in adults with childhood onset AD/HD and/or autism spectrum disorders. J Neural Trans. 2004;111:891-902.
20.
Kim JA, Szatmari P., Bryson SE, et al. The prevalence of anxiety and mood problems among children with autism and Asperger syndrome. Autism. 2000 ;4:117-132.
21.
Russell AJ, Mataix-Cols D., Anson M., Murphy DMObsessions and compulsions in Asperger syndrome and high-functioning autism . Br J Psychiatry. 2005;186:525-528.
22.
McDougle CJ , Kresch LE, Goodman WK, et al. A case-controlled study of repetitive thoughts and behavior in adults with autistic disorder and obsessive-compulsive disorder. Am J Psychiatry.1995;152:772-777.
23.
McCracken JT , McGough J., Shah B., et al. Risperidone in children with autism and serious behavioral problems. N Engl J Med.2002;347:314-321.
24.
Rapin I.Autistic regression and disintegrative disorder: how important the role of epilepsy?Semin Pediatr Neurol.1995; 2:278-285.
25.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th Edition (DSM-IV). Washington, DC: American Psychiatric Association; 1994:65-78.
26.
Lainhart JE , Ozonoff S., Coon H., et al. Autism, regression, and the broader autism phenotype. Am J Med Genet.2002;13:231-237.
27.
Wakefield AJ , Puleston JM, Montgomery SM, et al. The concept of entero-colonic encephalopathy, autism, and opioid receptor ligands. Aliment Pharmacol Ther.2002;16:663-674.
28.
Wakefield AJ , Anthony A., Murch SH, et al. Enterocolitis in children with developmental disorders. Am J Gastroenterol.2000;95:2285-2295.
29.
Horvath K., Papadimitriou JC, Rabsztyn A.,Drachenberg C., Tildon JTGastrointestinal abnormalities in children with autistic disorder. J Pediatr.1999;135:559-563.
30.
Furlano RI, Anthony A., Day R., et al. Colonic CD8 and gamma delta T-cell infiltration with epithelial damage in children with autism. J Pediatr.2001;138:366-372.
31.
Torrente F. , Ashwood P., Day R., et al. Small intestinal enteropathy with epithelial IgG and complement deposition in children with regressive autism . Mol Psychiatry. 2002;7:375-382.
32.
Afzal N., Murch S., Thirrupathy K., Berger L., Fagbemi A., Heuschkel R.Constipation with acquired megarectum in children with autism. Pediatrics. 2003;112:939-942.
33.
Gupta S., Aggarwal S., Heads C.Brief report: dysregulated immune system in children with autism: beneficial effects of intravenous immune globulin on autistic characteristics. J Autism Dev Disord. 1996;26:87-97.
34.
Gupta S., Rimland B., Shilling PDPentoxifylline: brief review and rationale for its possible use in the treatment of autism. J Child Neurol.1996;11:501-504.
35.
Croonenberghs J., Bosmans E., Deboutte D., Kenis G., Maes M.Activation of the inflammatory response system in autism. Neuropsychobiology . 2002;45:1-6.
36.
Gillberg C.Early symptoms in autism. In: Gillberg C, ed. Diagnosis and Treatment of Autism. New York, NY: Plenum Press; 1989;23-32.
Towbin KE, Pradella A., Gorrindo T., Pine DS, Leibenluft E.Autism spectrum trained in children with mood and anxiety disorders. J Child Adolesc Psychopharmacol. 2005;15:452-464.
39.
Kurita H.Specificity and developmental consequences of speech loss I children with pervasive developmental disorders. Psychiatry Clin Neurosci.1996;50:181-184.
40.
Luyster R., Richler J., Risi S., et al. Early regression in social communication in autism spectrum disorders: a CPEA Study. Dev Neuropsychol.2005;27:311-336.
41.
Davidovitch M. , Glick L., Holtzman G., Tirosh E., Safir MPDevelopmental regression in autism: maternal perception. J Autism Dev Disord. 2000;30:113-119.
42.
Rush AJ, Keller MB, Bauer MS, et al; Mood Disorder Work Group. Diagnostic and Statistical Manual of Mental Disorders, 4th Edition. Washington DC: American Psychiatric Association; 1998:317-366.
43.
Tuchman RF, Rapin I., Shinnar S.Autistic and dysphasic children. II: Epilepsy. Pediatrics . 1991;88:1219-1225.
44.
Gillberg C., Coleman M.The Biology of the Autistic Syndromes. 3rd ed. London, UK: Mac Keith Press; 2000:185-187.
45.
Johnson DAGastroesophageal reflux disease and sleep disorders: a wake-up call for physicians and their patients. Rev Gastroenterol Disord. 2005;5(suppl 2):S3-S11.
46.
Tuchman RF, Rapin I.Regression in pervasive developmental disorders: seizures and epileptiform electroencephalogram correlates. Pediatrics. 1997;99:560-565.
47.
Chakrabarti S., Fombonne E.Pervasive developmental disorders in preschool children: confirmation of high prevalence. Am J Psychiatry.2005;162:1133-1141.
48.
Lewinsohn PM , Klein DN, Seeley J.Bipolar disorder during adolescence and young adulthood in a community sample. Bipolar Disord.2000;2:281-293.
49.
Verhulst F. , vander Ende J., Ferdinand R., Kasius M.The prevalence of DSM-III-R diagnoses in a national sample of Dutch adolescents. Arch Gen Psychiatry . 1997;54:329-336.
50.
Fombonne E.The Chartres Study: I. Prevalence of psychiatric disorders among French school-age children. Br J Psychiatry . 1994;164:69-79.
51.
Rutter M., Tizard J., Yule W., et al. Research report: Isle of Wight Studies, 1964-1974. Psych Med.1976;6:313-332.
52.
Pearson DA, Loveland KA, Lachar D., et al. A comparison of behavioral and emotional functioning in children and adolescents with autistic disorders and pervasive developmental disorders-not otherwise specified. Child Neuropsychol.2006 ;12:321-333.
53.
Costa E., Silva JASleep disorders in psychiatry. Metabolism. 2006;55(suppl 2):S40-S44.
54.
Challman TD , Barbaresi WJ, Katusic SK, Weaver A.The yield of the medical evaluation of children with pervasive developmental disorders. J Autism Dev Disord . 2003;33:187-192.
55.
Filipek PA, Accardo PJ, Ashwal S., et al. Practice parameter: screening and diagnosis of autism: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Child Neurology Society. Neurology. 2000;55:468-479.
